Today's Rundown Novartis tight-lipped on MedCo buyout rumors Myovant's oral prostate cancer drug matches incumbent in phase 3 Novo Ventures, Broad Institute form drug discovery pact Relay Therapeutics beefs up leadership as it looks to the clinic FDA to AstraZeneca to small biotech: Badrul Chowdhury on the move again Yumanity snags a CMO as Shire keeps bleeding execs PPD to go public once again Novartis taps growing Biofourmis for digital heart failure project Top 10 pharma settlements since 2018 Featured Story | | | Tuesday, November 19, 2019 The Medicines Company, fresh from its turn at the American Heart Association this weekend, has seen its shares jump on growing rumors that Swiss major Novartis may be interested in buying it out. |
|
|---|
|
Top Stories Tuesday, November 19, 2019 A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval next year. Tuesday, November 19, 2019 Novo Ventures has joined with the Broad Institute to support drug discovery projects. The partners will use $25 million in Novo Ventures’ money to fund drug discovery projects led by researchers at the Broad and affiliated organizations. Tuesday, November 19, 2019 Last year, Relay raised one of the largest private rounds in biotech, banking $400 million to propel a pipeline of treatments aiming at previously undruggable targets. Now, as it looks to enter the clinic in 2020, the company is adding a trio of biopharma vets, including Merck alum Iain Martin, Ph.D. to its leadership team. Tuesday, November 19, 2019 Less than two years after jumping ship from the FDA to AstraZeneca, Badrul Chowdhury, M.D., Ph.D., is joining a host of other former colleagues exiting from the U.K. Big Pharma with a move into biotech. Monday, November 18, 2019 As Takeda’s Shire buyout rumbles on, yet another R&D exec has found a new home. Brigitte Robertson, M.D., who led global development teams within Shire’s neuroscience division, is now Yumanity Therapeutics’ chief medical officer. Robertson follows a string of executive exits, including those of Shire's former R&D chief and CMO. Tuesday, November 19, 2019 Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans. Monday, November 18, 2019 Biofourmis has been tapped by Novartis to help develop digital therapeutic programs that follow patients home after they’ve been recently diagnosed with heart failure. At the same time, Biofourmis announced plans to acquire Biovotion, makers of clinical-grade wearable biosensors. Tuesday, November 19, 2019 A number of high-dollar settlements could be on the way as drugmakers look to bail on federal opioid suits. But the past two years have been thick with other deals to wrap up government investigations and lawsuits, from Medicaid fraud to False Claims Act actions. Enrollment Showcase Resources Sponsored by: Outer Edge Technology, LLC See why visionaries outsource the design and management of the infrastructure allowing their scientists to innovate. Sponsored by: Veeva Systems Medical Affairs 2025 brings together leading perspectives from AstraZeneca, Bristol-Myers Squibb, Merck, Lilly, and other innovative life sciences organizations on key challenges impacting medical affairs and a roadmap for success in the coming decade. Sponsored by: SHYFT Analytics This whitepaper provides a snapshot of where the biopharma industry is now, where it's heading, and how companies are allocating their resources to adapt & grow. Sponsored by: IBM Watson Health IBM’s highlighted solutions reside in a security-rich cloud environment—home for capturing, managing and analyzing clinical study data with control, accuracy and confidence. These solutions lay the groundwork for further integration with IBM® Watson® cognitive technology. Sponsored by: IBM Watson Health Inpatient View and Outpatient View are powered by robust data assets and use sophisticated projection methodologies to help ensure accuracy of reporting. Sponsored by: IBM Watson Health Acknowledging various stakeholder networks, as well as recognizing variances within the regulatory environment, we believe, is essential for companies looking to uncover the right decision-makers in support of biologics or biosimilars. Learn more. Sponsored by: ON24 Discover solutions to the most common challenges faced by medical device companies. Sponsored by: Eli Lilly and Company in partnership with Xcenda Download this complimentary paper that explores the practice of step therapy and its impact on key stakeholders in the US healthcare system. Sponsored by: Clarivate Analytics 18 high-value new licensing deals worth in excess of $500 million took place during the second quarter of 2019 -Get the Q2 2019 Biopharma licensing report for full details and insights. Sponsored by: Patheon, by Thermo Fisher Scientific Is your API development on track? Sponsored by: BBK Worldwide Get the latest data on how people are using apps to manage their health, and learn how you can leverage it in the development of your next clinical trial app. Sponsored by: Blue Latitude Health Report: How to design digital services that deliver value and improve outcomes for patients, healthcare professionals and the healthcare systems they serve Sponsored by: Article Galaxy powered by Reprints Desk This white paper examines the skyrocketing cost of drug development and provides step-by-step guidance for executing a successful fail fast strategy. Sponsored by: Roche and IQVIA A global landscape study of funding trends and innovations. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. Countdown to Drug Development Boot Camp® 2019 November 20-21, 2019 | Boston, MA | Register Now at www.drugstomarket.com/drugbootcamp and start Pre-Boot Camp Preparation FierceBiotech Executive Breakfast at the J.P. Morgan Healthcare Conference 2020 January 14, 2020 | The Fairmont Hotel | San Francisco, CA 4th Annual Gene Therapy for Rare Disorders March 30 – April 2, 2020 | Boston, MA A Rare Affair for Rare Diseases January 12, 2020 | San Francisco, CA | 